Research and Development

Showing 15 posts of 9596 posts found.

regeneron

Regeneron abandons respiratory syncytial virus therapy after late-stage failure

August 15, 2017 Manufacturing and Production, Research and Development RSV, Regeneron, pharma, pharmaceuticals, respiratory syncytial virus

Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …

Takeda strikes partnership to develop single-drug cancer combo immunotherapies

August 14, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, immunotherapy, medicine, pharma, pharmaceuticals

Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …
shutterstock_95714119

Over 1,000 currently active cancer trials spell trouble for patient recruitment

August 14, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, drugs, life sciences, medicine, pharma, pharmaceutical

The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …
brain-1787622_640

Early-stage study gives hope for rare and fatal neurodegenerative condition

August 11, 2017 Medical Communications, Research and Development biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …
shutterstock_87495637

Ending the era of $100,000 cancer drugs

August 11, 2017 Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Merck, NICE, Parkinson's, biotech, diabetes, pharma, pharmaceutical, top ten

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …
heart-2372134_640

Heart failure mortality rates fall across England and Wales, national audit finds

August 11, 2017 Medical Communications, Research and Development cardiovascular, heart, heart disease, life sciences, pharma, pharmaceutical

Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …
cancer-vs-alzheimer-1080x810

Cancer Research UK partners with Biotecnol to deliver experimental solid tumour drug

August 10, 2017 Research and Development, Sales and Marketing Biotecnol, Cancer, Cancer Research UK, drugs, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Cancer Research UK (CRUK) has announced a collaboration with Biotecnol, an immuno-oncology firm focused on the development of multifunctional antibodies …

Pioneering immunotherapy halts progression of type 1 diabetes

August 10, 2017 Research and Development Type 1 diabetes, diabetes, drugs, insulin, life sciences, medicines, pharma, pharmaceutical

In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …
rasmus-web

Alvotech recruit new CEO from within

August 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alvotech, biotech, drugs, pharma, pharmaceutical

Alvotech, a biopharmaceutical company focusing on the development and manufacture of based in Reykjavik, Iceland, has replaced outgoing CEO, Eef …
shutterstock_38078521

FDA awards orphan status to new brain cancer vaccine

August 9, 2017 Research and Development, Sales and Marketing FDA, life sciences, orphan drug, pharma, pharmaceuticals

The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the …
valeant

Valeant focused on bringing new products to market, receives CRL

August 9, 2017 Research and Development, Sales and Marketing Valeant, biotech, drugs, pharma, pharmaceutical

In its second quarter financial reports, Valeant strove to strike a positive note. It revealed that it had paid down …
The Gateway to Local Adoption Series

Latest content